A phase I study of a novel lipopolymer-based interleukin-12 gene therapeutic in combination with chemotherapy for the treatment of platinum-sensitive recurrent ovarian cancer

2011 ◽  
Vol 120 ◽  
pp. S32
Author(s):  
R. Alvarez ◽  
K. Anwar ◽  
M. Barnes ◽  
J. Fewell
Keyword(s):  
Ovarian Cancer ◽  
Phase I ◽  
Phase I Study ◽  
Recurrent Ovarian Cancer ◽  
Interleukin 12 ◽  
Platinum Sensitive

A phase I study of the vascular-disrupting agent BNC105P in combination with gemcitabine-carboplatin in platinum-sensitive ovarian cancer patients in first or second relapse.

2014 ◽  
Vol 32 (15_suppl) ◽  
pp. 5524-5524 ◽  
Author(s):  
Danny Rischin ◽  
Philip James Beale ◽  
Emma Caroline Rossi ◽  
Jeffrey C. Goh ◽  
Michelle Margaret Vaughan ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Phase I ◽  
Cancer Patients ◽  
Phase I Study ◽  
Vascular Disrupting Agent ◽  
Platinum Sensitive ◽  
Vascular Disrupting

A phase I study of bevacizumab in combination with niraparib in patients with platinum-sensitive epithelial ovarian cancer: The ENGOT-OV24/AVANOVA1 trial.

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. 5555-5555 ◽  
Author(s):  
Mansoor Raza Mirza ◽  
Christiane Ehlers Mortensen ◽  
Rene dePont Christensen ◽  
Louise Christoffersen ◽  
Mia Westergaard ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Phase I ◽  
Epithelial Ovarian Cancer ◽  
Phase I Study ◽  
Platinum Sensitive

A phase I study of a p53MVA vaccine in combination with gemcitabine (GEM) in recurrent ovarian cancer (OC).

2016 ◽  
Vol 34 (15_suppl) ◽  
pp. e17040-e17040
Author(s):  
Mihaela C. Cristea ◽  
Nicola Hardwick ◽  
Paul Henry Frankel ◽  
Robert Morgan ◽  
Lucille A. Leong ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Phase I ◽  
Phase I Study ◽  
Recurrent Ovarian Cancer

Fixed-dose rate gemcitabine plus carboplatin in relapsed, platinum-sensitive ovarian cancer patients: Results of a three-arm Phase I study

2009 ◽  
Vol 115 (3) ◽  
pp. 389-395 ◽  
Author(s):  
Ronald D. Alvarez ◽  
Robert Mannel ◽  
Agustin A. García ◽  
Holly H. Gallion ◽  
Joseph Lucci ◽  
...  
Keyword(s):  
Ovarian Cancer ◽  
Phase I ◽  
Dose Rate ◽  
Cancer Patients ◽  
Phase I Study ◽  
Fixed Dose ◽  
Platinum Sensitive ◽  
Fixed Dose Rate
Sign in / Sign up

Export Citation Format

Share Document